Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
doi: 10.1038/s41598-018-30779-x
[1] This extended half-life allows for convenient weekly dosing while maintaining stable blood glucose control and appetite suppression throughout the week
Both medications enhanced insulin secretion and reduced appetite, but tirzepatides dual action on GIP and GLP-1 pathways provides broader metabolic benefits including improved lipid profiles, blood pressure, and biomarkers of insulin sensitivity
Bajramagic S, et al
Independent replication of some findings strengthens the evidence base
"It's clear that there is a very large market opportunity but it also takes a portfolio of products that cater for different patient needs," Fruergaard Jrgensen noted.
